Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16359345 | 0.87 | THRB (0.35) | THRBTSHRALDH1A1 | |
| SCHEMBL4569285 | 0.86 | ALDH1A1 (0.35) | THRBTSHRALDH1A1 | |
| SCHEMBL22013202 | 0.85 | ALDH1A1 (0.36) | THRBTSHRALDH1A1 | |
| SCHEMBL18545341 | 0.85 | THRB (0.43) | THRBTSHRALDH1A1 | |
| SCHEMBL18458188 | 0.84 | THRB (0.38) | THRBTSHRALDH1A1 | |
| SCHEMBL13264751 | 0.84 | THRB (0.33) | THRBTSHR | |
| SCHEMBL347723 | 0.83 | ALDH1A1 (0.42) | THRBTSHRALDH1A1 | |
| SCHEMBL19201602 | 0.83 | BTN3A1 (0.31) | — | |
| SCHEMBL19085379 | 0.83 | TSHR (0.49) | THRBTSHR | |
| SCHEMBL17659967 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219336-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM CORPORATION (JP) | 2023-07-13 | — | — | US | disclosed |
| US-9579608-B2 | Composite membranes and methods of preparation thereof | GLOBALFOUNDRIES INC. (KY) | 2017-02-28 | — | — | US | disclosed |
| US-9012581-B2 | Ophthalmic and otorhinolaryngological device materials | NOVARTIS AG (CH) | 2015-04-21 | — | — | US | disclosed |
| US-20120107264-A1 | NUCLEIC ACID DELIVERY COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120107264-A1 | NUCLEIC ACID DELIVERY COMPOUNDS | HNRNPH3, NSUN2, SNRPA | THRB 3298/4885TSHR 2852/4885ALDH1A1 2549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.